Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis

Advances in Pharmacological Sciences

Volumn 2011, Issue , 2011, Pages

  Oshiro, Satoru ^a   Morioka, Masaki S ^b   Kikuchi, Masataka ^c  

^a DAITO BUNKA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 PROPARGYLPIPERAZIN 1 YLMETHYL) 8 HYDROXYQUINOLINE; [5 (N METHYL N PROPARGYAMINOMETHYL) 8 HYDROXYQUINOLINE]; ANTIOXIDANT; CHELATING AGENT; DEFERIPRONE; DEFEROXAMINE; FERALEX G; HEMERYTHRIN; IRON; IRON REGULATORY FACTOR; IRON RESPONSIVE ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG;

AGRANULOCYTOSIS; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BRAIN DAMAGE; BRAIN METABOLISM; FRIEDREICH ATAXIA; GLIA CELL; HEMOCHROMATOSIS; HUMAN; IRON CHELATION; IRON METABOLISM; IRON METABOLISM DISORDER; IRON RESPONSIVE ELEMENT; LIVER TOXICITY; NERVE CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; QUALITY OF LIFE; REVIEW; ZINC DEFICIENCY;

EID: 84555179169     PISSN: 16876334     EISSN: 16876342     Source Type: Journal    
DOI: 10.1155/2011/378278     Document Type: Review

References (72)

1. Andrews N. C., Disorders of iron metabolism New England Journal of Medicine 1999 341 26 1986 1995 (Pubitemid 30010408)
2. Flanagan P. R., Intestinal Iron Metabolism and Absorption 1990 New York, NY, USA CRC Press edited by P. Ponka, H. M. Schulman, R. C. Woodworth
3. Oshiro S., Kawahara M., Mika S., Muramoto K., Kobayashi K., Ishige R., Nozawa K., Hori M., Yung C., Kitajima S., Kuroda Y., Aluminum taken up by transferrin-independent iron uptake affects the iron metabolism in rat cortical cells Journal of Biochemistry 1998 123 1 42 46 (Pubitemid 28068563)
4. Oshiro S., Nakamura Y., Ishige R., Hori M., Nakajima H., Gahl W. A., Reduction site of transferrin-dependent and transferrin-independent iron in cultured human fibroblasts Journal of Biochemistry 1994 115 5 849 852 (Pubitemid 24159906)
5. McKie A. T., Barrow D., Latunde-Dada G. O., Rolfs A., Sager G., Mudaly E., Mudaly M., Richardson C., Barlow D., Bomford A., Peters T. J., Raja K. B., Shirali S., Hediger M. A., Farzaneh F., Simpson R. J., An iron-regulated ferric reductase associated with the absorption of dietary iron Science 2001 291 5509 1755 1759 (Pubitemid 32198974)
6. Knopfel M., Solioz M., Characterization of a cytochrome b 558 ferric/cupric reductase from rabbit duodenal brush border membranes Biochemical and Biophysical Research Communications 2002 291 2 220 225 (Pubitemid 34694393)
7. Gunshin H., Mackenzie B., Berger U. V., Gunshin Y., Romero M. F., Boron W. F., Nussberger S., Gollan J. L., Hediger M. A., Cloning and characterization of a mammalian proton-coupled metal-ion transporter Nature 1997 388 6641 482 488 (Pubitemid 27328927)
8. Donovan A., Brownlie A., Zhou Y., Shepard J., Pratt S. J., Moynihan J., Paw B. H., Drejer A., Barut B., Zapata A., Law T. C., Brugnara C., Lux S. E., Pinkus G. S., Pinkus J. L., Kingsley P. D., Palls J., Fleming M. D., Andrews N. C., Leonard Z., Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter Nature 2000 403 6771 776 781 (Pubitemid 30111839)
9. Vulpe C. D., Kuo Y. M., Murphy T. L., Cowley L., Askwith C., Libina N., Gitschier J., Anderson G. I., Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse Nature Genetics 1999 21 2 195 199 (Pubitemid 29070366)
10. Fleming R. E., Sly W. S., Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease Proceedings of the National Academy of Sciences of the United States of America 2001 98 15 8160 8162 (Pubitemid 32678004)
11. Vashisht A. A., Zumbrennen K. B., Huang X., Powers D. N., Durazo A., Sun D., Bhaskaran N., Persson A., Uhlen M., Sangfeit O., Spruck C., Leibold E. A., Wohlschlegel J. A., Control of iron homeostasis by an iron-regulated ubiquitin ligase Science 2009 326 5953 718 721
12. Salahudeen A. A., Thompson J. W., Ruiz J. C., Ma H. W., Kinch L. N., Li Q., Grishin N. V., Bruick R. K., An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis Science 2009 326 5953 722 726
13. Moos T., Morgan E. H., The metabolism of neuronal iron and its pathogenic role in neurological disease review Annals of the New York Academy of Sciences 2004 1012 14 26 (Pubitemid 38453512)
14. Cheah J. H., Kim S. F., Hester L. D., Clancy K. W., Patterson S. E., Papadopoulos V., Snyder S. H., NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1 Neuron 2006 51 4 431 440 (Pubitemid 44209322)
15. Klomp L. W., Farhangrazi Z. S., Dugan L. L., Gitlin J. D., Ceruloplasmin gene expression in the murine central nervous system Journal of Clinical Investigation 1996 98 1 207 215 (Pubitemid 26243838)
16. Espinosa de los Monteros A., Chiapelli F., Fisher R. S., de Vellis J., Transferrin: an early marker of oligodendrocytes in culture International Journal of Developmental Neuroscience 1988 6 2 167 175
17. Oshiro S., Kawamura K., Zhang C., Sone T., Morioka M. S., Kobayashi S., Nakajima K., Microglia and astroglia prevent oxidative stress-induced neuronal cell death: implications for aceruloplasminemia Biochimica et Biophysica Acta 2008 1782 2 109 117
18. Yamamoto A., Shin R. W., Hasegawa K., Naiki H., Sato H., Yoshimasu F., Kitamoto T., Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease Journal of Neurochemistry 2002 82 5 1137 1147 (Pubitemid 34966626)
19. Smith M. A., Harris P. L., Sayre L. M., Perry G., Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proceedings of the National Academy of Sciences of the United States of America 1997 94 18 9866 9868 (Pubitemid 27408156)
20. Takahashi R. H., Almeida C. G., Kearney P. F., Yu F., Lin M. T., Milner T. A., Gouras G. K., Oligomerization of Alzheimer's -amyloid within processes and synapses of cultured neurons and brain Journal of Neuroscience 2004 24 14 3592 3599 (Pubitemid 38481116)
21. Ivins K. J., Bui E. T., Cotman C. W., -amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis Neurobiology of Disease 1998 5 5 365 378 (Pubitemid 29037288)
22. Haass C., Hung A. Y., Selkoe D. J., Processing of -amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion Journal of Neuroscience 1991 11 12 3783 3793
23. Duce J. A., Tsatsanis A., Cater M. A., James S. A., Robb E., Wikhe K., Leong S. L., Perez K., Johanssen T., Greenough M. A., Cho H. H., Galatis D., Moir R. D., Masters C. L., McLean C., Tanzi R. E., Cappai R., Barnham K. J., Ciccotosto G. D., Rogers J. T., Bush A. I., Iron-export ferroxidase activity of -amyloid precursor protein is inhibited by zinc in Alzheimer's disease Cell 2010 142 6 857 867
24. Zecca L., Youdim M. B., Riederer P., Connor J. R., Crichton R. R., Iron, brain ageing and neurodegenerative disorders Nature Reviews Neuroscience 2004 5 11 863 873 (Pubitemid 39482155)
25. Rogers J. T., Bush A. I., Cho H. H., Smith D. H., Thomson A. M., Friedrlich A. L., Lahiri D. K., Leedman P. J., Huang X., Cahill C. M., Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease Biochemical Society Transactions 2008 36 6 1282 1287
26. Cho H. H., Cahill C. M., Vanderburg C. R., Scherzer C. R., Wang B., Huang X., Rogers J. T., Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1 Journal of Biological Chemistry 2010 285 41 31217 31232
27. Mueller C., Magaki S., Schrag M., Ghosh M. C., Kirsch W. M., Iron regulatory protein 2 is involved in brain copper homeostasis Journal of Alzheimer's Disease 2009 18 1 201 210
28. Bodovitz S., Falduto M. T., Frail D. E., Klein W. L., Iron levels modulate -secretase cleavage of amyloid precursor protein Journal of Neurochemistry 1995 64 1 307 315
29. Rogers J. T., Leiter L. M., McPhee J., Cahill C. M., Zhan S. S., Potter H., Nilsson L. N. G., Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5 ′ -untranslated region sequences Journal of Biological Chemistry 1999 274 10 6421 6431 (Pubitemid 29111057)
30. Sampath P., Mazumder B., Seshadri V., Fox P. L., Transcript-selective translational silencing by gamma interferon is directed by a novel structural element in the ceruloplasmin mRNA 3 ′ untranslated region Molecular and Cellular Biology 2003 23 5 1509 1519 (Pubitemid 36246034)
31. Hirsch E. C., Brandel J. P., Galle P., Javoy-Agid F., Agid Y., Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis Journal of Neurochemistry 1991 56 2 446 451 (Pubitemid 21901982)
32. Sofic E., Paulus W., Jellinger K., Riederer P., Youdim M. B., Selective increase of iron in substantia nigra zona compacta of Parkinsonian brains Journal of Neurochemistry 1991 56 3 978 982 (Pubitemid 21922711)
33. Song N., Jiang H., Wang J., Xie J. X., Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx Journal of Neuroscience Research 2007 85 14 3118 3126 (Pubitemid 350057367)
34. Rogers J. T., Mikkilineni S., Cantuti-Castelvetri I., Smith D. H., Huang X., Bandyopadhyay S., Cahill C. M., Maccecchini M. L., Lahiri D. K., Greig N. H., The alpha-synuclein 5 ′ untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen Journal of Neural Transmission 2011 118 3 493 507
35. Danzeisen R., Achsel T., Bederke U., Cozzolino M., Crosio C., Ferri A., Frenzel M., Gralla E. B., Huber L., Ludolph A., Nencini M., Rotilio G., Valentine J. S., Carr M. T., Superoxide dismutase 1 modulates expression of transferrin receptor Journal of Biological Inorganic Chemistry 2006 11 4 489 498 (Pubitemid 44012032)
36. Gerlach M., Riederer P., Double K. L., Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease Parkinsonism and Related Disorders 2008 14 supplement 2 S185 S188
37. Du F., Qian Z. M., Zhu L., Wu X. M., Yung W. H., Tsim T. Y., Ke Y., L-DOPA neurotoxicity is mediated by up-regulation of DMT1-IRE expression PLoS One 2009 4 2
38. Salazar J., Mena N., Hunot S., Prigent A., Alvarez-Fischer D., Arredondo M., Duyckaerts C., Sazdovitch V., Zhao L., Garrick L. M., Nuez M. T., Garrick M. D., Raisman-Vozari R., Hirsch E. C., Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 2008 105 47 18578 18583
39. Jin L., Wang J., Zhao L., Jin H., Fei G., Zhang Y., Zeng M., Zhong C., Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease Brain 2011 134 1 50 58
40. Viswanath V., Wu Y., Boonplueang R., Chen S., Stevenson F. F., Yantiri F., Yang L., Flint Beal M., Andersen J. K., Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Parkinson's disease Journal of Neuroscience 2001 21 24 9519 9528 (Pubitemid 34184040)
41. Kasarskis E. J., Tandon L., Lovell M. A., Ehmann W. D., Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study Journal of the Neurological Sciences 1995 130 2 203 208
42. Li X., Jankovic J., Le W., Iron chelation and neuroprotection in NDs Journal of Neural Transmission 2011 118 3 473 477
43. Yoshida M., Takahashi Y., Koike A., Fukuda Y., Goto J., Tsuji S., A mutation database for amyotrophic lateral sclerosis Human Mutation 2010 31 9 1003 1010
44. Elden A. C., Kim H. J., Hart M. P., Chen-Plotkin A. S., Johnson B. S., Fang X., Armakola M., Geser F., Greene R., Lu M. M., Padmanabhan A., Clay-Falcone D., McCluskey L., Elman L., Juhr D., Gruber P. J., Rb U., Auburger G., Trojanowski J. Q., Lee V. M. Y., Van Deerlin V. M., Bonini N. M., Gitler A. D., Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS Nature 2010 466 7310 1069 1075
45. Buratti E., Baralle F. E., Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9 Journal of Biological Chemistry 2001 276 39 36337 36343
46. Ayala V., Granado-Serrano A. B., Cacabelos D., Naud A., Ilieva E. V., Boada J., Caraballo-Miralles V., Llad J., Ferrer I., Pamplona R., Portero-Otin M., Cell stress induces TDP-43 pathological changes associated with ERK1/2 dysfunction: implications in ALS Acta Neuropathologica 2011 122 3 259 270
47. Kudo L. C., Parfenova L., Vi N., Lau K., Pomakian J., Valdmanis P., Rouleau G. A., Vinters H. V., Wiedau-Pazos M., Karsten S. L., Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis Human Molecular Genetics 2010 19 16 3233 3253
48. Henkel J. S., Beers D. R., Siklos L., Appel S. H., The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS Molecular and Cellular Neuroscience 2006 31 3 427 437 (Pubitemid 43358017)
49. Ward R. J., Crichton R. R., Taylor D. L., Delia Corte L., Srai S. K., Dexter DT Iron and the immune system Journal of Neural Transmission 2011 118 3 315 328
50. Bolognin S., Drago D., Messori L., Zatta P., Chelation therapy for NDs Medicinal Research Reviews 2009 29 4 547 570
51. Woehler F., The treatment of hemochromatosis with desferioxamine Acta Haematologica 1963 30 65 87
52. Shachar D. B., Eshel G., Finberg J. P., Youdim M. B. H., The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons Journal of Neurochemistry 1991 56 4 1441 1444 (Pubitemid 21902069)
53. Youdim M. B. H., Fridkin M., Zheng H., Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other NDs Journal of Neural Transmission 2004 111 10-11 1455 1471 (Pubitemid 39468399)
54. Cuajungco M. P., Lees G. J., Diverse effects of metal chelating agents on the neuronal cytotoxicity of zinc in the hippocampus Brain Research 1998 799 1 97 107 (Pubitemid 28351209)
55. Bring P., Partovi N., Ford J. A., Yoshida E. M., Iron overload disorders: treatment options for patients refractory to or intolerant of phlebotomy Pharmacotherapy 2008 28 3 331 342 (Pubitemid 351328906)
56. Goncalves S., Paupe V., Dassa E. P., Rustin P., Deferiprone targets aconitase: implication for Friedreich's ataxia treatment BMC Neurology 2008 8, article 20
57. Luangasanatip N., Chaiyakunapruk N., Upakdee N., Wong P., Iron-chelating therapies in a transfusion-dependent thalassaemia population in Thailand: a cost-effectiveness study Clinical Drug Investigation 2011 31 7 493 505
58. Kontoghiorghes G. J., Kolnagou A., Peng C. T., Shah S. V., Aessopos A., Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases Expert Opinion on Drug Safety 2010 9 2 201 206
59. Tanner M. A., Galanello R., Dessi C., Smith G. C., Westwood M. A., Agus A., Pibiri M., Nair S. V., Walker J. M., Pennell D. J., Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction Journal of Cardiovascular Magnetic Resonance 2008 10 1, article 12
60. Zareifar S., Jabbari A., Cohan N., Haghpanah S., Efficacy of combined desferrioxamine and deferiprone versus single desferrioxamine therapy in patients with major thalassemia Archives of Iranian Medicine 2009 12 5 488 491
61. Kruck T. P., Burrow T. E., Synthesis of feralex a novel aluminum/iron chelating compound Journal of Inorganic Biochemistry 2002 88 1 19 24 (Pubitemid 34003046)
62. Shin R. W., Kruck T. P., Murayama H., Kitamoto T., A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease Brain Research 2003 961 1 139 146 (Pubitemid 36090130)
63. Kruck T. P., Percy M. E., Lukiw W. J., Metal sulfate-mediated induction of pathogenic genes and repression by phenyl butyl nitrone and Feralex-G NeuroReport 2008 19 2 245 249
64. Kupershmidt L., Weinreb O., Amit T., Mandel S., Bar-Am O., Youdim M. B., Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain Neuroscience 2011 189 345 358
65. Weinreb O., Mandel S., Bar-Am O., Amit T., Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim Journal of Neural Transmission 2011 118 3 479 492
66. Wang Q., Zhang X., Chen S., Zhang X., Zhang S., Youdium M., Le W., Prevention of motor neuron degeneration by novel iron chelators in SOD1 G93A transgenic mice of amyotrophic lateral sclerosis Neurodegenerative Diseases 2011 8 5 310 321
67. Kupershmidt L., Weinreb O., Amit T., Mandel S., Carri M. T., Youdim M. B., Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis FASEB Journal 2009 23 11 3766 3779
68. Youdim M. B., Edmondson D., Tipton K. F., The therapeutic potential of monoamine oxidase inhibitors Nature Reviews Neuroscience 2006 7 4 295 309
69. Tanaka J., Toku K., Zhang B., Ishihara K., Sakanaka M., Maeda N., Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species Glia 1999 28 2 85 96 (Pubitemid 29530608)
70. Toku K., Tanaka J., Yano H., Desaki J., Zhang B., Yang L., Ishihara K., Sakanaka M., Maeda N., Microglial cells prevent nitric oxide-induced neuronal apoptosis in vitro Journal of Neuroscience Research 1998 53 4 415 425 (Pubitemid 28363203)
71. Piani D., Spranger M., Frei K., Schaffner A., Fontana A., Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines European Journal of Immunology 1992 22 9 2429 2436
72. Polazzi E., Gianni T., Contestabile A., Microglial cells protect cerebellar granule neurons from apoptosis: evidence for reciprocal signaling Glia 2001 36 3 271 280 (Pubitemid 34010056)